Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial of Thymalfasin (Ta1) to Prevent COVID-19 Infection in Renal Dialysis Patients

NCT04428008 is registered in ClinicalTrials.gov with William B. Ershler, MD as lead sponsor.

NCT NCT04428008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04428008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial of Thymalfasin (Ta1) to Prevent COVID-19 Infection in Renal Dialysis Patients
Lead sponsor
William B. Ershler, MD
Phase
Phase 2
Overall status
Completed
Start date
January 12, 2021
Completion date
January 19, 2023
Enrollment
189 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19